F2 and hepatocellular carcinoma: The Child-Turcotte-Pugh (CTP) qualitative scoring system is used to assess severity of cirrhosis, survival prospects hepatic reserve, guiding treatment decisions, and stratifying patients with hepatocellular carcinoma (HCC) for clinical trial entry; It classifies patients with liver disease into 3 groups (A, B, and C), this classification is based on bilirubin and albumin levels, prothrombin time, and subjective assessments of encephalopathy and ascites [1, 2].